BACKGROUND: Pentoxifylline (PTX) has been shown to reduce hepatic injury after normothermic ischemia and reperfusion (I-R) in rat liver. AIM: The aim of this study was to evaluate the effects of PTX on liver expression of tumor necrosis factor alpha (TNFalpha) mRNA following normothermic liver I-R. MATERIALS AND METHODS: A segmental normothermic ischemia of the liver was induced in male Lewis rats by occluding the blood vessels including the bile duct to the median and left lateral lobes for 90 min. At the end of ischemia the nonischemic liver lobes were resected. Rats were divided into three groups: group 1, control Ringer lactate administration; group 2, PTX treatment; group 3, sham-operated control rats. PTX (50 mg/kg) was injected intravenously 30 min before and 60 min after induction of ischemia. Survival rates were compared and the serum activities of TNFalpha, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) were measured. Histology of the liver was assessed 6 h after reperfusion. Liver TNFalpha mRNA was assessed by PCR amplification at 0, 60, 120, and 210 min after reperfusion. RESULTS: PTX treatment significantly increased 7 day survival (93.3%) compared with nontreated control rats (46.6%, p<0.007). The extent of liver necrosis and the release of liver enzymes were significantly decreased after PTX treatment. Serum activities of TNFalpha were significantly decreased and liver expression of TNFalpha mRNA was inhibited after PTX treatment. CONCLUSION: PTX protects the liver from ischemic injury and inhibits liver expression of TNFalpha mRNA.
BACKGROUND:Pentoxifylline (PTX) has been shown to reduce hepatic injury after normothermic ischemia and reperfusion (I-R) in rat liver. AIM: The aim of this study was to evaluate the effects of PTX on liver expression of tumor necrosis factor alpha (TNFalpha) mRNA following normothermic liver I-R. MATERIALS AND METHODS: A segmental normothermic ischemia of the liver was induced in male Lewis rats by occluding the blood vessels including the bile duct to the median and left lateral lobes for 90 min. At the end of ischemia the nonischemic liver lobes were resected. Rats were divided into three groups: group 1, control Ringer lactate administration; group 2, PTX treatment; group 3, sham-operated control rats. PTX (50 mg/kg) was injected intravenously 30 min before and 60 min after induction of ischemia. Survival rates were compared and the serum activities of TNFalpha, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) were measured. Histology of the liver was assessed 6 h after reperfusion. Liver TNFalpha mRNA was assessed by PCR amplification at 0, 60, 120, and 210 min after reperfusion. RESULTS:PTX treatment significantly increased 7 day survival (93.3%) compared with nontreated control rats (46.6%, p<0.007). The extent of liver necrosis and the release of liver enzymes were significantly decreased after PTX treatment. Serum activities of TNFalpha were significantly decreased and liver expression of TNFalpha mRNA was inhibited after PTX treatment. CONCLUSION:PTX protects the liver from ischemic injury and inhibits liver expression of TNFalpha mRNA.
Authors: H Iwamoto; K Kozaki; N Nakamura; K Hama; K Narumi; N Matsuno; K Kuzuoka; S Taira; Y Kihara; M Uchiyama; H Takeuchi; T Nagao Journal: Transplant Proc Date: 2002-11 Impact factor: 1.066
Authors: M Goto; Y Takei; S Kawano; S Tsuji; H Fukui; H Fushimi; Y Nishimura; T Kashiwagi; H Fusamoto; T Kamada Journal: Hepatology Date: 1992-08 Impact factor: 17.425
Authors: R Cursio; J Gugenheim; P Panaia-Ferrari; A Lasfar; M Tovey; S Chastanet; M C Saint-Paul; C Ferré; J Mouiel Journal: J Surg Res Date: 1998-12 Impact factor: 2.192
Authors: Mahmoud Abu-Amara; Kurinchi Selvan Gurusamy; George Glantzounis; Barry Fuller; Brian R Davidson Journal: Cochrane Database Syst Rev Date: 2009-10-07
Authors: Mohammed Reza Moussavian; Claudia Scheuer; Michael Schmidt; Otto Kollmar; Matthias Wagner; Maximilian von Heesen; Martin K Schilling; Michael D Menger Journal: Langenbecks Arch Surg Date: 2010-06-27 Impact factor: 3.445
Authors: Edmond Raymond Le Campion; Jose Jukemura; Ana Maria Coelho; Rosely Patzina; Luiz Augusto Carneiro D'Albuquerque Journal: HPB (Oxford) Date: 2012-12-17 Impact factor: 3.647
Authors: Edson A Ribeiro; Luiz F Poli-de-Figueiredo; Rodrigo Vincenzi; Flavio H F Galvao; Nelson Margarido; Mauricio Rocha-E-Silva; Ruy J Cruz Journal: HPB Surg Date: 2013-08-29